{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:29:11Z","timestamp":1770071351910,"version":"3.49.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Research Foundation of Luzhou City and Southwest Medical University","award":["2018LZXNYD-YL01"],"award-info":[{"award-number":["2018LZXNYD-YL01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34442-0","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:38:09Z","timestamp":1768232289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel variant p.Y250C of FZD4 influences Norrine\/\u03b2-catenin signaling pathway that associates with familial exudative vitreoretinopathy (FEVR)"],"prefix":"10.1038","volume":"16","author":[{"given":"Lisha","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingliang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maomei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"34442_CR1","doi-asserted-by":"publisher","first-page":"5782536","DOI":"10.1155\/2019\/5782536","volume":"2019","author":"H Xiao","year":"2019","unstructured":"Xiao, H., Tong, Y., Zhu, Y. & Peng, M. Familial exudative vitreoretinopathy-related disease-causing genes and Norrin\/\u03b2-catenin signal pathway: structure, function, and mutation spectrums. J. Ophthalmol. 2019, 5782536 (2019).","journal-title":"J. Ophthalmol."},{"issue":"7","key":"34442_CR2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/genes12070980","volume":"12","author":"L Huang","year":"2021","unstructured":"Huang, L. et al. Whole-gene deletions of FZD4 cause familial exudative vitreoretinopathy. Genes 12(7), 980 (2021).","journal-title":"Genes"},{"issue":"1","key":"34442_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/7681926","volume":"2020","author":"S Han","year":"2020","unstructured":"Han, S., Sun, J., Yang, L. & Qi, M. Role of NDP- and FZD4-related novel mutations identified in patients with fevr in norrin\/\u03b2-catenin signaling pathway. BioMed. Res. Intl. 2020(1), 1\u201311 (2020).","journal-title":"BioMed. Res. Intl."},{"issue":"1","key":"34442_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000535714","volume":"15","author":"M Akada","year":"2024","unstructured":"Akada, M., Nagasawa, T. & Tabuchi, H. Successful management of familial exudative vitreoretinopathy with a large macular hole using inverted internal limiting membrane flap technique. Case Rep. Ophthalmol. 15(1), 129\u2013135 (2024).","journal-title":"Case Rep. Ophthalmol."},{"issue":"11","key":"34442_CR5","doi-asserted-by":"publisher","first-page":"1409074","DOI":"10.3389\/fmed.2024.1409074","volume":"26","author":"YJ Zhang","year":"2024","unstructured":"Zhang, Y. J., Chen, S. M. & Xiu, Y. H. FEVR combined with macular heterotopia in children presenting as pseudo-exotropia: A case report and literature review. Front Med. 26(11), 1409074 (2024).","journal-title":"Front Med."},{"issue":"21","key":"34442_CR6","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.3390\/cells12212579","volume":"12","author":"V Le","year":"2023","unstructured":"Le, V. et al. Mechanisms underlying rare inherited pediatric retinal vascular diseases: FEVR, Norrie disease, persistent fetal vascular syndrome. Cells 12(21), 2579 (2023).","journal-title":"Cells"},{"issue":"3","key":"34442_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/genes13030495","volume":"13","author":"AP Cicerone","year":"2022","unstructured":"Cicerone, A. P. et al. A survey of multigenic protein-altering variant frequency in familial exudative vitreo-retinopathy (FEVR) patients by targeted sequencing of seven FEVR-linked genes. Genes 13(3), 495 (2022).","journal-title":"Genes"},{"issue":"2","key":"34442_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/iovs.66.2.23","volume":"66","author":"SVD Ende","year":"2025","unstructured":"Ende, S. V. D. et al. Gene variant spectrum in probands with familial exudative vitreoretinopathy using an expanded panel. Invest Ophthalmol. Vis. Sci. 66(2), 23 (2025).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"4","key":"34442_CR9","first-page":"164","volume":"45","author":"S S\u0131zmaz","year":"2015","unstructured":"S\u0131zmaz, S., Yonekawa, Y. & Trese, M. T. Familial exudative vitreoretinopathy. T\u00fcrk J. Ophthamolii. 45(4), 164\u2013168 (2015).","journal-title":"T\u00fcrk J. Ophthamolii."},{"issue":"2","key":"34442_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cell.2009.09.027","volume":"139","author":"H Clevers","year":"2009","unstructured":"Clevers, H. Eyeing up new Wnt pathway players. Cell 139(2), 227\u2013229 (2009).","journal-title":"Cell"},{"issue":"6","key":"34442_CR11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ajhg.2017.05.001","volume":"100","author":"ES Panagiotou","year":"2017","unstructured":"Panagiotou, E. S. et al. Defects in the cell signaling mediator \u03b2-catenin cause the retinal vascular condition FEVR. Am. J. Humn. Genet. 100(6), 960\u2013968 (2017).","journal-title":"Am. J. Humn. Genet."},{"issue":"3","key":"34442_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.65.3.31","volume":"65","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. Investigating the impact of dimer interface mutations on norrin\u2019s secretion and Norrin\/\u03b2-catenin pathway activation. Invest Ophthalmal. Vis. Sci. 65(3), 31 (2024).","journal-title":"Invest Ophthalmal. Vis. Sci."},{"issue":"1","key":"34442_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald, B. T., Tamai, K. & He, X. Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell. 17(1), 9\u201326 (2009).","journal-title":"Dev. Cell."},{"key":"34442_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.preteyeres.2018.11.008","volume":"70","author":"Z Wang","year":"2019","unstructured":"Wang, Z., Liu, C. H., Huang, S. & Chen, J. Wnt signaling in vascular eye diseases. Prog. Retin. Eye Res. 70, 110\u2013133 (2019).","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"34442_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12876-019-0957-5","volume":"19","author":"K G\u00f6tzel","year":"2019","unstructured":"G\u00f6tzel, K. et al. In-depth characterization of the Wnt-signaling\/\u03b2-catenin pathway in an in vitro model of Barrett\u2019s sequence. BMC Gastroenterol. 19(1), 38 (2019).","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"34442_CR16","first-page":"773","volume":"41","author":"Y Lin","year":"2018","unstructured":"Lin, Y. et al. Clinical and next-generation sequencing findings in a Chinese family exhibiting severe familial exudative vitreoretinopathy. Int. J. Mol. Med. 41(2), 773\u2013782 (2018).","journal-title":"Int. J. Mol. Med."},{"issue":"12","key":"34442_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/dvdy.117","volume":"248","author":"L Caceres","year":"2019","unstructured":"Caceres, L. et al. Frizzled 4 regulates ventral blood vessel remodeling in the zebrafish retina. Dev. Dyn. 248(12), 1243\u20131256 (2019).","journal-title":"Dev. Dyn."},{"issue":"Pt 1","key":"34442_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.128570","volume":"258","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Frameshift variants in the C-terminal of CTNNB1 cause familial exudative vitreoretinopathy by AXIN1-mediated ubiquitin-proteasome degradation condensation. Int. J. Biol. Macromol. 258(Pt 1), 128570 (2024).","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"34442_CR19","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1159\/000495901","volume":"51","author":"L Yang","year":"2018","unstructured":"Yang, L. et al. A novel variant of the FZD4 gene in a Chinese family causes autosomal dominant familial exudative vitreoretinopathy. Cell Physiol. Biochem. 51(5), 2445\u20132455 (2018).","journal-title":"Cell Physiol. Biochem."},{"issue":"4","key":"34442_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/ceo.14037","volume":"50","author":"R Zhao","year":"2022","unstructured":"Zhao, R. et al. Heterozygote loss-of-function variants in the LRP5 gene cause familial exudative vitreoretinopathy. Clin. Exp. Ophthalmol. 50(4), 441\u2013448 (2022).","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"6","key":"34442_CR21","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1177\/11206721221074209","volume":"32","author":"Y Peng","year":"2022","unstructured":"Peng, Y. et al. Whole-exome sequencing reveals novel NDP variants in x-linked familial exudative vitreoretinopathy. Eur. J. Ophthalmol. 32(6), 3220\u20133226 (2022).","journal-title":"Eur. J. Ophthalmol."},{"issue":"3","key":"34442_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/genes14030587","volume":"14","author":"Z Jiang","year":"2023","unstructured":"Jiang, Z. & Wang, P. Novel Exon 7 deletions in TSPAN12 in a three-generation FEVR family: A case report and literature review. Genes (Basel). 14(3), 587 (2023).","journal-title":"Genes (Basel)."},{"issue":"9","key":"34442_CR23","doi-asserted-by":"publisher","first-page":"300060523119451","DOI":"10.1177\/03000605231194518","volume":"51","author":"X Tao","year":"2023","unstructured":"Tao, X. et al. Genetic and clinical characteristics of ZNF408-related familial exudative vitreoretinopathy. J. Int. Med. Res. 51(9), 3000605231194518 (2023).","journal-title":"J. Int. Med. Res."},{"key":"34442_CR24","first-page":"528","volume":"27","author":"KZ Wang","year":"2021","unstructured":"Wang, K. Z., Zhang, X., Tian, T. & Zhao, P. Q. Identification of a novel mutation in KIF11 with functional analysis in a cohort of 516 familial patients with exudative vitreoretinopathy. Molr. Vis. 27, 528\u2013541 (2021).","journal-title":"Molr. Vis."},{"issue":"6","key":"34442_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139869","volume":"131","author":"X Zhu","year":"2021","unstructured":"Zhu, X. et al. Catenin \u03b1 1 mutations cause familial exudative vitreoretinopathy by overactivating Norrin\/\u03b2-catenin signaling. J. Clin. Invest. 131(6), e139869 (2021).","journal-title":"J. Clin. Invest."},{"issue":"2","key":"34442_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/iovs.64.2.18","volume":"64","author":"L Huang","year":"2023","unstructured":"Huang, L., Lu, J., Wang, Y., Sun, L. & Ding, X. Familial exudative vitreoretinopathy and systemic abnormalities in patients with CTNNB1 mutations. Invest. Ophthalmol. Vis. Sci. 64(2), 18 (2023).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"14","key":"34442_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.158428","volume":"7","author":"M Yang","year":"2022","unstructured":"Yang, M. et al. CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt\/cadherin axis. JCI Insight. 7(14), e158428 (2022).","journal-title":"JCI Insight."},{"issue":"1","key":"34442_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41436-019-0571-5","volume":"22","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Exome sequencing revealed Notch ligand JAG1 as a novel candidate gene for familial exudative vitreoretinopathy. Genet. Med. 22(1), 77\u201384 (2020).","journal-title":"Genet. Med."},{"issue":"8","key":"34442_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/hmg\/ddw041","volume":"25","author":"JH Wu","year":"2016","unstructured":"Wu, J. H. et al. Haploinsufficiency of RCBTB1 is associated with Coats disease and familial exudative vitreoretinopathy. Hum. Mol. Genet. 25(8), 1637\u20131647 (2016).","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"34442_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/hmg\/ddr509","volume":"21","author":"K Khan","year":"2012","unstructured":"Khan, K. et al. Next generation sequencing identifies mutations in Atonal homolog 7 (ATOH7) in families with global eye developmental defects. Hum. Mol. Genet. 21(4), 776\u2013783 (2012).","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"34442_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/bjo.2004.042507","volume":"89","author":"C Toomes","year":"2005","unstructured":"Toomes, C. Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree. Br. J. Ophthalmol. 89(2), 194\u2013197 (2005).","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"34442_CR32","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/s41467-019-13220-3","volume":"10","author":"H Park","year":"2019","unstructured":"Park, H. et al. Integrin-linked kinase controls retinal angiogenesis and is linked to Wnt signaling and exudative vitreoretinopathy. Nat. Commun. 10(1), 2543 (2019).","journal-title":"Nat. Commun."},{"issue":"5","key":"34442_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/gtmb.2021.0013","volume":"25","author":"SA-O Zhang","year":"2021","unstructured":"Zhang, S.A.-O. et al. Whole-exome sequencing identified DLG1 as a Candidate gene for familial exudative vitreoretinopathy. Genet Test Mol. Biomarkers. 25(5), 309\u2013316 (2021).","journal-title":"Genet Test Mol. Biomarkers."},{"issue":"6","key":"34442_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jgg.2021.11.010","volume":"49","author":"S Li","year":"2022","unstructured":"Li, S. et al. Variants in the Wnt co-receptor LRP6 are associated with familial exudative vitreoretinopathy. J. Genet. Genomics. 49(6), 590\u2013594 (2022).","journal-title":"J. Genet. Genomics."},{"issue":"5","key":"34442_CR35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/13816810.2021.1938137","volume":"42","author":"T Asano","year":"2021","unstructured":"Asano, T., Oku, K. & Kondo, H.A.-O.X. Familial exudative vitreoretinopathy with TGFBR2 mutation without signs of Loeys-Dietz syndrome. Ophthalmic Genet. 42(5), 637\u2013640 (2021).","journal-title":"Ophthalmic Genet."},{"issue":"6","key":"34442_CR36","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.gendis.2022.10.003","volume":"10","author":"S Li","year":"2023","unstructured":"Li, S. et al. Defective EMC1 drives abnormal retinal angiogenesis via Wnt\/\u03b2-catenin signaling and may be associated with the pathogenesis of familial exudative vitreoretinopathy. Genes Dis. 10(6), 2572\u20132585 (2023).","journal-title":"Genes Dis."},{"issue":"2","key":"34442_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1089\/gtmb.2019.0212","volume":"24","author":"X Zhu","year":"2020","unstructured":"Zhu, X. et al. Identification of novel mutations in the FZD4 and NDP genes in patients with familial exudative vitreoretinopathy in South India. Genet Test Mol. Biomarkers. 24(2), 92\u201398 (2020).","journal-title":"Genet Test Mol. Biomarkers."},{"issue":"4","key":"34442_CR38","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/genes13040713","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Update on the phenotypic and genotypic spectrum of KIF11-related retinopathy. Genes 13(4), 713 (2022).","journal-title":"Genes"},{"issue":"5","key":"34442_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2024.100514","volume":"4","author":"H Kondo","year":"2024","unstructured":"Kondo, H. et al. Familial exudative vitreoretinopathy with and without pathogenic variants of Norrin\/\u03b2-catenin signaling genes. Ophthalmol Sci. 4(5), 100514 (2024).","journal-title":"Ophthalmol Sci."},{"issue":"1","key":"34442_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12920-022-01204-0","volume":"15","author":"H Dan","year":"2022","unstructured":"Dan, H. et al. Whole exome sequencing revealed 14 variants in NDP, FZD4, LRP5, and TSPAN12 genes for 20 families with familial exudative vitreoretinopathy. BMC Med. Genomics. 15(1), 54 (2022).","journal-title":"BMC Med. Genomics."},{"issue":"5","key":"34442_CR41","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1167\/iovs.16-21324","volume":"58","author":"FQ Rao","year":"2017","unstructured":"Rao, F. Q. et al. Mutations in LRP5, FZD4, TSPAN12, NDP, ZNF408, or KIF11 genes account for 38.7% of Chinese patients with familial exudative vitreoretinopathy. Invest Opthalmo Vis. Sci. 58(5), 2623\u20132629 (2017).","journal-title":"Invest Opthalmo Vis. Sci."},{"issue":"1","key":"34442_CR42","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1080\/07853890.2022.2146744","volume":"54","author":"J Mao","year":"2022","unstructured":"Mao, J. et al. Clinical characteristics and mutation spectrum in 33 Chinese families with familial exudative vitreoretinopathy. Ann. Med. 54(1), 3285\u20133297 (2022).","journal-title":"Ann. Med."},{"key":"34442_CR43","first-page":"60","volume":"25","author":"T Tian","year":"2019","unstructured":"Tian, T., Zhang, X., Zang, Q. & Zhao, P. Variable reduction in Norrin signaling activity caused by novel mutations in FZD4 identified in patients with familial exudative vitreoretinopathy. Mol Vis. 25, 60\u201369 (2019).","journal-title":"Mol Vis."},{"issue":"1","key":"34442_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s42003-022-03370-4","volume":"5","author":"SB Ko","year":"2022","unstructured":"Ko, S. B. et al. Functional role of the Frizzled linker domain in the Wnt signaling pathway. Commun. Biol. 5(1), 421 (2022).","journal-title":"Commun. Biol."},{"issue":"4","key":"34442_CR45","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1124\/pr.110.002931","volume":"62","author":"G Schulte","year":"2010","unstructured":"Schulte, G. The class frizzled receptors. Pharmacol Rev. 62(4), 632\u2013667 (2010).","journal-title":"Pharmacol Rev."},{"issue":"1","key":"34442_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s10020-019-0129-7","volume":"26","author":"RM Milhem","year":"2019","unstructured":"Milhem, R. M. & Ali, B. R. Disorders of FZ-CRD; insights towards FZ-CRD folding and therapeutic landscape. Mol Med. 26(1), 4 (2019).","journal-title":"Mol Med."},{"issue":"6","key":"34442_CR47","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1074\/jbc.M609618200","volume":"282","author":"PM Smallwood","year":"2007","unstructured":"Smallwood, P. M., Williams, J., Xu, Q., Leahy, D. J. & Nathans, J. Mutational analysis of Norrin-Frizzled4 recognition. J. Bio. Chem. 282(6), 4057\u20134068 (2007).","journal-title":"J. Bio. Chem."},{"issue":"21","key":"34442_CR48","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1101\/gad.228544.113","volume":"27","author":"JY Ke","year":"2013","unstructured":"Ke, J. Y. et al. Structure and function of Norrin in assembly and activation of a Frizzled 4\u2013Lrp5\/6 complex. Genes D. 27(21), 2305\u20132319 (2013).","journal-title":"Genes D."},{"issue":"4","key":"34442_CR49","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/0002-9394(69)91237-9","volume":"68","author":"CL Criswick Vg Fau Schepens","year":"1969","unstructured":"Criswick Vg Fau Schepens, C. L. & Schepens, C. L. Familial exudative vitreoretinopathy. Am. J. Ophthalmol. 68(4), 578\u2013594 (1969).","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"34442_CR50","first-page":"176","volume":"7","author":"Z Tauqeer","year":"2018","unstructured":"Tauqeer, Z. & Yonekawa, Y. Familial Exudative Vitreoretinopathy: Pathophysiology, Diagnosis, and Management. Asia Pac. J. Ophthalmol (Phila). 7(3), 176\u2013182 (2018).","journal-title":"Asia Pac. J. Ophthalmol (Phila)."},{"issue":"1","key":"34442_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12886-023-02884-7","volume":"23","author":"S Liu","year":"2023","unstructured":"Liu, S. et al. Vascular features around the optic disc in familial exudative vitreoretinopathy findings and their relationship to disease severity. BMC Ophthalmol. 23(1), 139 (2023).","journal-title":"BMC Ophthalmol."},{"issue":"13","key":"34442_CR52","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1167\/iovs.17-23541","volume":"59","author":"JK Li","year":"2018","unstructured":"Li, J. K. et al. Spectrum of variants in 389 Chinese probands with familial exudative vitreoretinopathy. Invest Opthalmol Vis. Sci. 59(13), 5368\u20135381 (2018).","journal-title":"Invest Opthalmol Vis. Sci."},{"issue":"9","key":"34442_CR53","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1167\/iovs.14-15680","volume":"56","author":"SH Seo","year":"2015","unstructured":"Seo, S. H. et al. Molecular characterization of FZD4, LRP5, and TSPAN12 in familial exudative vitreoretinopathy. Invest Opthalmol. Vis Sci. 56(9), 5143\u20135151 (2015).","journal-title":"Invest Opthalmol. Vis Sci."},{"issue":"192","key":"34442_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.107941","volume":"2020","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. The spectrum of genetic mutations in patients with asymptomatic mild familial exudative vitreoretinopathy. Exp. Eye Res. 2020(192), 107941 (2020).","journal-title":"Exp. Eye Res."},{"issue":"2","key":"34442_CR55","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/aos.16701","volume":"103","author":"L L\u00e4hteenoja","year":"2025","unstructured":"L\u00e4hteenoja, L. et al. Clinical and genetic characteristics and natural history of Finnish families with familial exudative vitreoretinopathy due to pathogenic FZD4 variants. Acta Ophthalmol. 103(2), 152\u2013161 (2025).","journal-title":"Acta Ophthalmol."},{"issue":"7","key":"34442_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271326","volume":"17","author":"R Tzekov","year":"2022","unstructured":"Tzekov, R., Wang, X., Chen, J., Xiong, H. & Yu, X. Genotype-phenotype associations in familial exudative vitreoretinopathy: A systematic review and meta-analysis on more than 3200 individuals. PLoS ONE 17(7), e0271326 (2022).","journal-title":"PLoS ONE"},{"issue":"1","key":"34442_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bjophthalmol-2019-315598","volume":"105","author":"SY Wang","year":"2021","unstructured":"Wang, S. Y. et al. Clinical and genetical features of probands and affected family members with familial exudative vitreoretinopathy in a large Chinese cohort. Br. J. Ophthalmol. 105(1), 83\u201386 (2021).","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"34442_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/iovs.63.4.7","volume":"63","author":"J Lu","year":"2022","unstructured":"Lu, J. et al. FZD4 in a Large Chinese population with familial exudative vitreoretinopathy: Molecular characteristics and clinical manifestations. Invest Ophthalmol. Vis. Sci. 63(4), 7 (2022).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"12","key":"34442_CR59","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1074\/jbc.M110.194399","volume":"286","author":"K Zhang","year":"2011","unstructured":"Zhang, K. et al. An essential role of the cysteine-rich domain of FZD4 in Norrin\/Wnt signaling and familial exudative vitreoretinopathy. J. Bio. Chem. 286(12), 10210\u201310215 (2011).","journal-title":"J. Bio. Chem."},{"issue":"4","key":"34442_CR60","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/bjo.2010.190116","volume":"95","author":"JM Robitaille","year":"2010","unstructured":"Robitaille, J. M. et al. The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease. Br. J. Ophthalmol. 95(4), 574\u2013579 (2010).","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"34442_CR61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.66.2.9","volume":"66","author":"FY Tuncay","year":"2025","unstructured":"Tuncay, F. Y. et al. Genotype-phenotype spectrum of eyeGENE patients with familial exudative vitreoretinopathy: Novel variants in Norrin\/beta-catenin signaling pathway genes. Invest Ophthalmol. Vis Sci. 66(2), 9 (2025).","journal-title":"Invest Ophthalmol. Vis Sci."},{"issue":"7720","key":"34442_CR62","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41586-018-0447-x","volume":"560","author":"S Yang","year":"2018","unstructured":"Yang, S. et al. Crystal structure of the Frizzled 4 receptor in a ligand-free state. Nature 560(7720), 666\u2013670 (2018).","journal-title":"Nature"},{"issue":"13","key":"34442_CR63","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.celrep.2017.06.004","volume":"19","author":"MB Lai","year":"2017","unstructured":"Lai, M. B. et al. TSPAN12 Is a Norrin co-receptor that amplifies Frizzled4 ligand selectivity and signaling. Cell Rep. 19(13), 2809\u20132822 (2017).","journal-title":"Cell Rep."},{"issue":"2","key":"34442_CR64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2009.07.048","volume":"139","author":"HJ Junge","year":"2009","unstructured":"Junge, H. J. et al. TSPAN12 regulates retinal vascular development by promoting Norrin- but Not Wnt-Induced FZD4\/\u03b2-catenin signaling. Cell 139(2), 299\u2013311 (2009).","journal-title":"Cell"},{"issue":"3","key":"34442_CR65","volume":"2","author":"ES Bruguera","year":"2025","unstructured":"Bruguera, E. S., Mahoney, J. P. & Weis, W. I. The co-receptor Tspan12 directly captures Norrin to promote ligandspecific \u03b2-catenin signaling. Elife 2(3), 578714 (2025).","journal-title":"Elife"},{"issue":"11","key":"34442_CR66","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3390\/pharmaceutics14112476","volume":"14","author":"H Nguyen","year":"2022","unstructured":"Nguyen, H., Lee, S. J. & Li, Y. Selective activation of the wnt-signaling pathway as a novel therapy for the treatment of diabetic retinopathy and other retinal vascular diseases. Pharmaceutics. 14(11), 2476 (2022).","journal-title":"Pharmaceutics."},{"issue":"6","key":"34442_CR67","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1167\/iovs.14-13885","volume":"55","author":"RM Milhem","year":"2014","unstructured":"Milhem, R. M., Ben-Salem, S., Al-Gazali, L. & Ali, B. R. Identification of the cellular mechanisms that modulate trafficking of frizzled family receptor 4 (FZD4) missense mutants associated with familial exudative vitreoretinopathy. Invest Opthalmol Vis Sci. 55(6), 3423\u20133431 (2014).","journal-title":"Invest Opthalmol Vis Sci."},{"issue":"2","key":"34442_CR68","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/ng957","volume":"32","author":"J Robitaille","year":"2002","unstructured":"Robitaille, J. et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat. Genet. 32(2), 326\u2013330 (2002).","journal-title":"Nat. Genet."},{"issue":"1","key":"34442_CR69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ncb1081","volume":"6","author":"A Kaykas","year":"2004","unstructured":"Kaykas, A. et al. Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization. Nat. Cell Biol. 6(1), 52\u201358 (2004).","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"34442_CR70","doi-asserted-by":"publisher","first-page":"8614","DOI":"10.1167\/iovs.14-15693","volume":"55","author":"A Rattner","year":"2014","unstructured":"Rattner, A., Wang, Y., Zhou, Y., Williams, J. & Nathans, J. The role of the hypoxia response in shaping retinal vascular development in the absence of Norrin\/Frizzled4 signaling. Invest Ophthalmol. Vis. Sci. 55(12), 8614\u20138625 (2014).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"5","key":"34442_CR71","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/13816810.2025.2505910","volume":"46","author":"J Liu","year":"2025","unstructured":"Liu, J., Zhang, Y. & Zhang, Z. The diagnostic value of ultra-widefield fundus imaging technology in early familial exudative vitreoretinopathy. Ophthalmic Genet. 46(5), 426\u2013434 (2025).","journal-title":"Ophthalmic Genet."},{"issue":"21","key":"34442_CR72","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.3390\/cells12212579","volume":"12","author":"V Le","year":"2023","unstructured":"Le, V. et al. Mechanisms underlying rare inherited pediatric retinal vascular diseases: FEVR, Norrie disease, persistent fetal vascular syndrome. Cells 12(21), 2579 (2023).","journal-title":"Cells"},{"key":"34442_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2025.101387","volume":"108","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Phenotyping and genotyping FEVR: Molecular genetics, clinical and imaging features, and therapeutics. Prog. Retin Eye Res. 108, 101387 (2025).","journal-title":"Prog. Retin Eye Res."},{"issue":"5","key":"34442_CR74","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00417-024-06695-4","volume":"263","author":"V Chaudhary","year":"2025","unstructured":"Chaudhary, V. et al. Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases. Graefes Arch. Clin. Exp. Ophthalmol. 263(5), 1239\u20131247 (2025).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"38","key":"34442_CR75","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cellsig.2017.06.018","volume":"2017","author":"K Strakova","year":"2017","unstructured":"Strakova, K. et al. The tyrosine Y250(2.39) in Frizzled 4 defines a conserved motif important for structural integrity of the receptor and recruitment of Disheveled. Cell Signal. 2017(38), 85\u201396 (2017).","journal-title":"Cell Signal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34442-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34442-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34442-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:03:26Z","timestamp":1770030206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34442-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34442"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34442-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research received approval from the Human Ethics Committee of Southwest Medical University\u00a0(No.:\u00a0KY2021237) and the Animal Ethics Committee of Southwest Medical University in China (No.: 20220928-003). Informed consent form was secured from either the family members or the guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All animal experiments were performed in accordance with ARRIVE 2.0 guidelines. All the steps\/ methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human or animal rights"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4438"}}